177 related articles for article (PubMed ID: 14680449)
1. Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors.
Sawyer TK
Expert Opin Investig Drugs; 2004 Jan; 13(1):1-19. PubMed ID: 14680449
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.
Wong MS; Sidik SM; Mahmud R; Stanslas J
Clin Exp Pharmacol Physiol; 2013 May; 40(5):307-19. PubMed ID: 23534409
[TBL] [Abstract][Full Text] [Related]
3. Novel anticancer drug discovery.
Buolamwini JK
Curr Opin Chem Biol; 1999 Aug; 3(4):500-9. PubMed ID: 10419854
[TBL] [Abstract][Full Text] [Related]
4. Src and focal adhesion kinase as therapeutic targets in cancer.
Brunton VG; Frame MC
Curr Opin Pharmacol; 2008 Aug; 8(4):427-32. PubMed ID: 18625340
[TBL] [Abstract][Full Text] [Related]
5. The design of drug candidate molecules as selective inhibitors of therapeutically relevant protein kinases.
Fischer PM
Curr Med Chem; 2004 Jun; 11(12):1563-83. PubMed ID: 15180564
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the research and development of RAF kinase inhibitors.
Smith RA; Dumas J; Adnane L; Wilhelm SM
Curr Top Med Chem; 2006; 6(11):1071-89. PubMed ID: 16842147
[TBL] [Abstract][Full Text] [Related]
7. Protein phosphorylation and signal transduction modulation: chemistry perspectives for small-molecule drug discovery.
Sawyer TK; Shakespeare WC; Wang Y; Sundaramoorthi R; Huang WS; Metcalf CA; Thomas M; Lawrence BM; Rozamus L; Noehre J; Zhu X; Narula S; Bohacek RS; Weigele M; Dalgarno DC
Med Chem; 2005 May; 1(3):293-319. PubMed ID: 16787325
[TBL] [Abstract][Full Text] [Related]
8. Targeting focal adhesion kinase signaling in tumor growth and metastasis.
Schwock J; Dhani N; Hedley DW
Expert Opin Ther Targets; 2010 Jan; 14(1):77-94. PubMed ID: 20001212
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the discovery of small molecule c-Met Kinase inhibitors.
Parikh PK; Ghate MD
Eur J Med Chem; 2018 Jan; 143():1103-1138. PubMed ID: 29157685
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs.
Zhang J; Jiang X; Jiang Y; Guo M; Zhang S; Li J; He J; Liu J; Wang J; Ouyang L
Eur J Med Chem; 2016 Jan; 108():495-504. PubMed ID: 26717201
[TBL] [Abstract][Full Text] [Related]
11. A historical overview of protein kinases and their targeted small molecule inhibitors.
Roskoski R
Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update.
Arunesh GM; Shanthi E; Krishna MH; Sooriya Kumar J; Viswanadhan VN
Expert Opin Ther Pat; 2014 Jan; 24(1):5-17. PubMed ID: 24131033
[TBL] [Abstract][Full Text] [Related]
13. Novel oncogenic protein kinase inhibitors for cancer therapy.
Sawyer TK
Curr Med Chem Anticancer Agents; 2004 Sep; 4(5):449-55. PubMed ID: 15379702
[TBL] [Abstract][Full Text] [Related]
14. Progress in the Development of Eukaryotic Elongation Factor 2 Kinase (eEF2K) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy.
Zhang B; Zou J; Zhang Q; Wang Z; Wang N; He S; Zhao Y; Naman CB
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673713
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
Jia L; Ma S
Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
[TBL] [Abstract][Full Text] [Related]
16. Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer.
Bera H; Chigurupati S
Eur J Med Chem; 2016 Nov; 124():992-1003. PubMed ID: 27783978
[TBL] [Abstract][Full Text] [Related]
17. Novel bone-targeted Src tyrosine kinase inhibitor drug discovery.
Shakespeare WC; Metcalf CA; Wang Y; Sundaramoorthi R; Keenan T; Weigele M; Bohacek RS; Dalgarno DC; Sawyer TK
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):729-41. PubMed ID: 14579523
[TBL] [Abstract][Full Text] [Related]
18. High-throughput structural biology in drug discovery: protein kinases.
Stout TJ; Foster PG; Matthews DJ
Curr Pharm Des; 2004; 10(10):1069-82. PubMed ID: 15078142
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase inhibitors: insights into drug design from structure.
Noble ME; Endicott JA; Johnson LN
Science; 2004 Mar; 303(5665):1800-5. PubMed ID: 15031492
[TBL] [Abstract][Full Text] [Related]
20. Enzyme inhibition as a key target for the development of novel metal-based anti-cancer therapeutics.
Griffith D; Parker JP; Marmion CJ
Anticancer Agents Med Chem; 2010 Jun; 10(5):354-70. PubMed ID: 20380633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]